Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Hatteras Venture Partners is a prominent venture capital firm founded in the Research Triangle, North Carolina. Established with a mission to build transformational companies in the healthcare sector, Hatteras focuses on early-stage investments in biotech, MedTech, and HealthTech. The firm has a strong reputation for its thoughtful investment strategies, which emphasize identifying high-quality science and teams that have the potential to significantly impact patient care. Hatteras has successfully raised multiple funds, although specific fund sizes and assets under management (AUM) are not publicly disclosed. The firm is well-regarded within the healthcare innovation community for its commitment to supporting companies that are at the forefront of therapeutic and diagnostic technologies. With a geographic focus on North America, Hatteras Venture Partners is strategically positioned to leverage the rich ecosystem of healthcare innovation in the region.
Hatteras Venture Partners invests primarily in early-stage companies that are innovating within the healthcare sector. Their investment focus encompasses a broad range of areas, including therapeutic and diagnostic technologies, which are critical for advancing patient care. The firm is particularly interested in companies that are developing solutions in biotech, MedTech, and HealthTech. Hatteras seeks to partner with high-quality teams that demonstrate significant potential for impact, emphasizing a rigorous evaluation process to identify promising science and innovative approaches. The firm typically invests at various stages, including pre-seed, seed, seed-plus, and Series A, allowing them to support companies from their inception through early growth phases. By concentrating on healthcare innovation, Hatteras aims to foster advancements that can lead to improved patient outcomes and transformative changes in the industry.
Hatteras Venture Partners boasts a diverse portfolio of notable investments in the healthcare sector. Among its key portfolio companies is **410 Medical**, which develops innovative resuscitation technologies aimed at enhancing emergency and critical care. Another significant investment is **Aer Therapeutics**, a clinical-stage biopharmaceutical company focused on inhaled therapies for chronic lung diseases. **Atsena Therapeutics** is also part of their portfolio, specializing in gene therapy for inherited retinal diseases. Additionally, **Cardiosense** combines wearable sensors with artificial intelligence to detect early signs of cardiac disease, showcasing the firm's commitment to cutting-edge technology. One of their most notable exits is **G1 Therapeutics, Inc.**, a commercial-stage biopharmaceutical company that successfully went public in May 2017. This diverse array of investments highlights Hatteras's strategic focus on companies that are pioneering advancements in healthcare.
Hatteras Venture Partners invests in early-stage companies, focusing on pre-seed, seed, seed-plus, and Series A stages. This allows them to support startups from their inception through early growth phases.
The firm specializes in the healthcare sector, particularly in biotech, MedTech, and HealthTech. They are particularly interested in therapeutic and diagnostic technologies that can significantly impact patient care.
While specific check sizes are not disclosed, Hatteras Venture Partners typically invests in early-stage companies, which suggests that their investments are tailored to the needs of startups at various stages of development.
Hatteras Venture Partners primarily focuses on investments within North America, leveraging the rich ecosystem of healthcare innovation present in the region.
Details regarding the application process are not specified in the available information. However, interested founders are encouraged to reach out directly to the firm for guidance on pitching their ideas.
While specific support mechanisms are not detailed, Hatteras Venture Partners is known for its commitment to fostering innovation and may provide strategic guidance and resources to its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.